These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 8990435)
21. Clinical evaluation of plasma fibronectin level as a biomarker of preeclampsia. Yasumizu T; Kato J J Obstet Gynaecol Res; 1996 Jun; 22(3):221-7. PubMed ID: 8840706 [TBL] [Abstract][Full Text] [Related]
22. The prediction of preeclampsia: reassessment of clinical value of increased plasma levels of fibronectin. Dreyfus M; Baldauf JJ; Ritter J; Van Cauwenberg JR; Hardy A; Foidart JM Eur J Obstet Gynecol Reprod Biol; 1998 May; 78(1):25-8. PubMed ID: 9605444 [TBL] [Abstract][Full Text] [Related]
23. Maternal plasma levels of cytokines in normal and preeclamptic pregnancies and their relationship with diastolic blood pressure and fibronectin levels. Madazli R; Aydin S; Uludag S; Vildan O; Tolun N Acta Obstet Gynecol Scand; 2003 Sep; 82(9):797-802. PubMed ID: 12911439 [TBL] [Abstract][Full Text] [Related]
24. Thrombomodulin, plasminogen activator inhibitor type 1 (PAI-1) and fibronectin as biomarkers of endothelial damage in preeclampsia and eclampsia. Shaarawy M; Didy HE Int J Gynaecol Obstet; 1996 Nov; 55(2):135-9. PubMed ID: 8960994 [TBL] [Abstract][Full Text] [Related]
25. Tumor necrosis factor-alpha in pregnancies associated with preeclampsia or small-for-gestational-age newborns. Schiff E; Friedman SA; Baumann P; Sibai BM; Romero R Am J Obstet Gynecol; 1994 May; 170(5 Pt 1):1224-9. PubMed ID: 8178841 [TBL] [Abstract][Full Text] [Related]
26. Increased maternal serum and cord blood fibronectin concentrations in preeclampsia are associated with higher placental hyaluronic acid and hydroxyproline content. Uzun H; Konukoglu D; Albayrak M; Benian A; Madazli R; Aydin S; Gelisgen R; Uludag S Hypertens Pregnancy; 2010 Jan; 29(2):153-62. PubMed ID: 20367505 [TBL] [Abstract][Full Text] [Related]
27. Endothelial vasoactive mediators in preeclampsia. Kraayenbrink AA; Dekker GA; van Kamp GJ; van Geijn HP Am J Obstet Gynecol; 1993 Jul; 169(1):160-5. PubMed ID: 8333445 [TBL] [Abstract][Full Text] [Related]
28. Biochemical corroboration of endothelial involvement in severe preeclampsia. Friedman SA; Schiff E; Emeis JJ; Dekker GA; Sibai BM Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):202-3. PubMed ID: 7847535 [TBL] [Abstract][Full Text] [Related]
29. Plasma fibronectin levels in preeclampsia: a possible biochemical marker for vascular endothelial damage. Stubbs TM; Lazarchick J; Horger EO Am J Obstet Gynecol; 1984 Dec; 150(7):885-7. PubMed ID: 6542311 [TBL] [Abstract][Full Text] [Related]
30. Maternal Cadmium Levels During Pregnancy and the Relationship with Preeclampsia and Fetal Biometric Parameters. Wang F; Fan F; Wang L; Ye W; Zhang Q; Xie S Biol Trace Elem Res; 2018 Dec; 186(2):322-329. PubMed ID: 29651732 [TBL] [Abstract][Full Text] [Related]
31. Increased umbilical cellular fibronectin concentrations are associated with a decreased prevalence of growth restriction in preeclampsia. Gilmour CH; Patrick TE; Roberts JM J Soc Gynecol Investig; 1999; 6(5):264-7. PubMed ID: 10554765 [TBL] [Abstract][Full Text] [Related]
32. Flow-mediated vasodilation and plasma fibronectin levels in preeclampsia. Yoshida A; Nakao S; Kobayashi M; Kobayashi H Hypertension; 2000 Sep; 36(3):400-4. PubMed ID: 10988272 [TBL] [Abstract][Full Text] [Related]
33. Maternal soluble vascular cytoplasmic adhesion molecule-1 and fibronectin levels in early- and late-onset preeclamptic pregnancies. Dogan E; Demir SC; Gulec UK Clin Exp Obstet Gynecol; 2014; 41(6):681-4. PubMed ID: 25551962 [TBL] [Abstract][Full Text] [Related]
34. Altered villus vessel fibronectin in preeclampsia. Anunciado AN; Stubbs TM; Pepkowitz SH; Lazarchick J; Miller CM; Pilia P Am J Obstet Gynecol; 1987 Apr; 156(4):898-900. PubMed ID: 3555079 [TBL] [Abstract][Full Text] [Related]
35. Are the maternal and umbilical VEGF-A and SVEGF-R1 altered in pregnancies complicated by preeclampsia with or without intrauterine foetal growth retardation? Preliminary communication. Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J Med Wieku Rozwoj; 2008; 12(1):499-506. PubMed ID: 18663270 [TBL] [Abstract][Full Text] [Related]
36. [Plasma concentration of biochemical markers in pre-eclampsia-eclampsia and its association with the severity of the disease]. Chavarría Olarte ME; González Gleason A; Lara González AL; Sojo Aranda I; García Paleta Y; Vital Reyes VS; Reyes Fuentes A Ginecol Obstet Mex; 2000 Sep; 68():385-93. PubMed ID: 11080945 [TBL] [Abstract][Full Text] [Related]
37. Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin. Bujold E; Romero R; Chaiworapongsa T; Kim YM; Kim GJ; Kim MR; Espinoza J; Gonçalves LF; Edwin S; Mazor M J Matern Fetal Neonatal Med; 2005 Jul; 18(1):9-16. PubMed ID: 16105786 [TBL] [Abstract][Full Text] [Related]
38. Homocysteine and cellular fibronectin are increased in preeclampsia, not transient hypertension of pregnancy. Powers RW; Evans RW; Ness RB; Crombleholme WR; Roberts JM Hypertens Pregnancy; 2001; 20(1):69-77. PubMed ID: 12044315 [TBL] [Abstract][Full Text] [Related]
39. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies. Holme AM; Roland MC; Henriksen T; Michelsen TM Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620 [TBL] [Abstract][Full Text] [Related]
40. Changes of plasma fibronectin levels in pregnancy induced hypertension. Paneva-Masin J; Zafirovska K; Bogdanovska S; Lozance L; Gerasimovska B Acta Med Croatica; 2000; 54(4-5):157-60. PubMed ID: 11379479 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]